SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-332215"
 

Search: id:"swepub:oai:DiVA.org:uu-332215" > Relative efficacy a...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Pollack, Charles V., Jr.Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA. (author)

Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2017-06-09
  • Wiley,2017
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-332215
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-332215URI
  • https://doi.org/10.1002/clc.22733DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Guidelines suggest that "upstream" P2Y(12) receptor antagonists should be considered in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS).Hypothesis: Early use of ticagrelor in patients managed with an invasive strategy would be more effective than clopidogrel because of its more rapid onset of action and greater potency.Methods: In the PLATO trial, 6792 NSTE-ACS patients were randomized to ticagrelor or clopidogrel (started prior to angiography) and underwent angiography within 72 hours of randomization. We compared efficacy and safety outcomes of ticagrelor vs clopidogrel as a function of "early" (<3h) vs "late" (>= 3h) time to angiography. Adjusted Cox proportional hazards models evaluated interaction between randomized treatment and time from randomization to angiography on subsequent outcomes.Results: Overall, a benefit of ticagrelor vs clopidogrel for cardiovascular death/myocardial infarction/stroke was seen at day 7 (hazard ratio [HR]: 0.67, P = 0.002), day 30 (HR: 0.81, P = 0.042), and 1 year (HR: 0.80, P = 0.0045). There were no significant interactions in the <3h vs >= 3h groups at any timepoint. For major bleeding, overall there was no significant increase (HR: 1.04, 95% confidence interval: 0.85-1.27); but there was a significant interaction with no difference between ticagrelor and clopidogrel in the early group (HR: 0.79), but higher bleeding risk with ticagrelor in the late angiography group, at 7 days (HR: 1.51, P-int = 0.002). Patterns were similar at 30 days and 1 year.Conclusions: The benefit of ticagrelor over clopidogrel was consistent in those undergoing early and late angiography, supporting upstream use of ticagrelor

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Davoudi, FaridehBrigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA. (author)
  • Diercks, Deborah B.Univ Texas Southwestern, Dept Emergency Med, Dallas, TX USA. (author)
  • Becker, Richard C.Univ Cincinnati, Coll Med, Heart Lung & Vasc Inst, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA. (author)
  • James, Stefan K,1964-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)stjam367 (author)
  • Lim, Soo TeikNatl Heart Ctr, Dept Cardiol, Singapore, Singapore. (author)
  • Schulte, Phillip J.Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA.;Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27706 USA. (author)
  • Spinar, JindrichMasaryk Univ, Dept Internal Med Cardiol, Brno, Czech Republic. (author)
  • Steg, Philippe GabrielHop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, Paris, France.;Paris Diderot Univ, Sorbonne Paris Cite, Paris, France.;NHLI Imperial Coll, Royal Brompton Hosp, ICMS, London, England.;FACT, INSERM, U1148, Paris, France. (author)
  • Storey, Robert F.Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England. (author)
  • Himmelmann, AndersAstraZeneca Res & Dev, Gothenburg, Sweden. (author)
  • Wallentin, Lars,1943-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall (author)
  • Cannon, Christopher P.Brigham & Womens Hosp, Baim Inst Clin Res, 75 Francis St, Boston, MA 02115 USA.;Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA. (author)
  • Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA.Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA. (creator_code:org_t)

Related titles

  • In:Clinical Cardiology: Wiley40:6, s. 390-3980160-92891932-8737

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view